Brain-penetrating molecule might offer a route to treat glioblastoma tumours

Mushtaq A. Nengroo and Issam Ben-Sahra ()

Nature, 2024, vol. 636, issue 8042, 307-308

Abstract: Gliocidin can target brain tumours by disrupting the production of nucleotides needed for cell growth. The molecule’s unusual ability to cross the blood–brain barrier suggests a promising way to develop therapies.

Keywords: Cancer; Medical research (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-024-03556-2 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:636:y:2024:i:8042:d:10.1038_d41586-024-03556-2

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-024-03556-2

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().